跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
TOBI tobramycin 300mg/5mL solution for inhalation ampoule
Approved
STANDARD
TOBI tobramycin 300mg/5mL solution for inhalation ampoule
Viatris Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
fe059d6f442d000d
Company
Viatris Pty Ltd
Type
Standard
Approval Details
Approval Id
fe059d6f442d000d
Product Name
TOBI tobramycin 300mg/5mL solution for inhalation ampoule
Artg Id
73172
Artg Name
TOBI tobramycin 300mg/5mL solution for inhalation ampoule
Sponsor
Viatris Pty Ltd
Company Detail Path
/organization/viatris-pty-ltd
Artg Date
2000-02-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4a1d3b4623bea53c36c28ade6c1f06e1.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/380cbfec37b76486bc13e6f4f5af099e.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
fe059d6f442d000d
Type
Standard
Back to TGA Approvals
TOBI tobramycin 300mg/5mL solution for inhalation ampoule - TGA Drug Approval Details
